EGFR and neoplasm: And for patients with systemic multiple lesions, repeated tumour biopsy is proposed in patients with resistance to EGFR-TKIs, which can analyze the possibility of resistance to EGFR-TKIs in order to select the most effective treatment, such as the third-generation EGFR-TKIs, which are recommended for patients who develop T790M.